Trial · NCT02533726
Optimal Patient Turning for Reducing Hospital Acquired Pressure Ulcers
NCT02533726, Not applicable, Completed, Stanford University; results first posted 2018-04-09
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Optimal Patient Turning for Reducing Hospital Acquired Pressure Ulcers. Trials, record NCT02533726. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02533726
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Optimal Patient Turning for Reducing Hospital Acquired Pressure Ulcers
- NCT number
- NCT02533726
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 1,312 participants, actual
- Lead sponsor
- Stanford University
- Conditions
- Pressure Ulcer
- Interventions
- Optimal Turning, Standard Care Practices, Patient Sensor
- First posted
- 2015-08-27
- Last updated
- 2018-04-09
- Results first posted
- 2018-04-09
Source ClinicalTrials.gov
Registered outcomes2
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Count of Participants With Pressure Ulcer According to the National Pressure Ulcer Advisory Panel (NPUAP) Criteria for Pressure Ulcers | Duration of ICU admission (average 1 week) | NPUAP criteria include 4 stages and 2 unstaged criteria. The count of patients with pressure ulcer according to any of the criteria are reported. * Stage 1: Non-blanchable erythema of intact skin * Stage 2: Partial-thickness skin loss with exposed dermis * Stage 3: Full-thickness skin loss * Stage 4: Full-thickness skin and tissue loss * Unstageable: Obscured full-thickness skin and tissue loss * Suspected deep tissue injury: Persistent non-blanchable deep red, maroon or purple discoloration |
| Secondary | Compliance With Patient Turning Procedures | Duration of ICU admission (average 1 week) | Compliance is reported as the percentage of time during ICU admission that patients received turning every two hours. |
Source ClinicalTrials.gov
Outcomes2
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Count of Participants With Pressure Ulcer According to the National Pressure Ulcer Advisory Panel (NPUAP) Criteria for Pressure Ulcers | Duration of ICU admission (average 1 week) | Per protocol population according to treatment received (met minimum monitoring period (\>2h) and did not receive both interventions) | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Compliance With Patient Turning Procedures | Duration of ICU admission (average 1 week) | Per protocol population according to treatment received (met minimum monitoring period (\>2h) and did not receive both interventions) | percentage of time | MEAN |
Source ClinicalTrials.gov
Results by group4
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Count of Participants With Pressure Ulcer According to the National Pressure Ulcer Advisory Panel (NPUAP) Criteria for Pressure Ulcers | Treatment - Optimal Turning | 5 | Participants | ||
| Count of Participants With Pressure Ulcer According to the National Pressure Ulcer Advisory Panel (NPUAP) Criteria for Pressure Ulcers | Control - Standard Care | 15 | Participants | ||
| Compliance With Patient Turning Procedures | Treatment - Optimal Turning | 67 | Standard Deviation 19.5 | percentage of time | |
| Compliance With Patient Turning Procedures | Control - Standard Care | 54 | Standard Deviation 22.3 | percentage of time |
Source ClinicalTrials.gov
Participant flow14
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Initial Allocation | STARTED | Treatment - Optimal Turning | 659 | |
| Initial Allocation | STARTED | Control - Standard Care | 653 | |
| Initial Allocation | COMPLETED | Treatment - Optimal Turning | 659 | |
| Initial Allocation | COMPLETED | Control - Standard Care | 653 | |
| Initial Allocation | NOT COMPLETED | Treatment - Optimal Turning | 0 | |
| Initial Allocation | NOT COMPLETED | Control - Standard Care | 0 | |
| Treatment | STARTED | Treatment - Optimal Turning | 709 | |
| Treatment | STARTED | Control - Standard Care | 603 | |
| Treatment | Per Protocol Population | Treatment - Optimal Turning | 671 | |
| Treatment | Per Protocol Population | Control - Standard Care | 555 |
1 to 10 of 14Source ClinicalTrials.gov
See all 14 participant flowAdverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals6
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Treatment - Optimal Turning | ||
| Total, all-cause mortality | Control - Standard Care | ||
| Total, other adverse events | Treatment - Optimal Turning | 0 | 709 |
| Total, other adverse events | Control - Standard Care | 0 | 603 |
| Total, serious adverse events | Treatment - Optimal Turning | 0 | 709 |
| Total, serious adverse events | Control - Standard Care | 0 | 603 |
Source ClinicalTrials.gov
Papers1
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as |
|---|---|
| 27053145 | DERIVED |
Source PubMed
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons2
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|---|
| Treatment - Optimal Turning vs Control - Standard Care: Count of Participants With Pressure Ulcer According to the National Pressure Ulcer Advisory Panel (NPUAP) Criteria for Pressure Ulcers | Trial comparisons |
| Treatment - Optimal Turning vs Control - Standard Care: serious adverse events | Trial comparisons |
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT02533726
GET https://conductscience.org/api/trials/v1/NCT02533726/registered